Medicare Bridge Program Prior Auth: Still work in progress at CMS?

PatchyFog

PatchyFog

Explorer
Joined
Feb 17, 2025
Messages
16
Reaction score
0
Location
California
Medicare's Bridge Program launches July 1st, giving seniors a way to get GLPs outside Part D at $50/month, and it's set to last 18 months.

CMS, which is Medicare's parent agency, has set up a webpage specifically for the Bridge Program:




Medicare GLP-1 Bridge | CMS



CMS unveiled the Better Approaches to Lifestyle and Nutrition for Comprehensive hEalth (BALANCE) Model, plus a distinct short-term demonstration that is now being called the “Medicare GLP-1 Bridge”

Image unavailable


www.cms.gov

...yet as things stand, the portal and procedure a Primary Care Provider would use to send in a prescription and prior auth for the Bridge Program still aren't available and remain a work-in-progress.

Has anyone heard otherwise?
 
I've come across the same thing — in a Facebook community for older GLP users. On top of that, certain physicians are reportedly refusing to file the paperwork at all, citing a lack of personnel to manage it, which leaves patients hunting for someone who will. In other words, exactly the mess you'd anticipate.
 
spanky2026 said:

I've come across the same thing — in a Facebook community for older GLP users. On top of that, certain physicians are reportedly refusing to file the paperwork at all, citing a lack of personnel to manage it, which leaves patients hunting for someone who will. In other words, exactly the mess you'd anticipate.
Click to expand...

Right. I happen to be among those jerks who have a concierge physician, so he'll comply with whatever I request, but it appears the portal/intake process hasn't been established yet. According to the website, Humanna will be operating the program (so I'm sure that'll go smoothly!) 🙂
 
PatchyFog said:

spanky2026 said:

I've come across the same thing — in a Facebook community for older GLP users. On top of that, certain physicians are reportedly refusing to file the paperwork at all, citing a lack of personnel to manage it, which leaves patients hunting for someone who will. In other words, exactly the mess you'd anticipate.
Click to expand...

Right. I happen to be among those jerks who have a concierge physician, so he'll comply with whatever I request, but it appears the portal/intake process hasn't been established yet. According to the website, Humanna will be operating the program (so I'm sure that'll go smoothly!) 🙂
Click to expand...
If that's the case, this program is headed straight for a trainwreck. 😵‍💫
 
My confidence that the government will mess up this entire program in no time is around negative 50 percent. Screwing things up is their specialty!
 
CVS Pharmacy Announces New GLP-1 Offerings, Including Expanded Pharmacy Support And A New $49 MinuteClinic Virtual Visit That Connects Eligible Adults With Licensed Clinicians#-cvs-pharmacy-announces-new-glp-1-...ects-eligible-adults-with-licensed-cliniciansBENZINGA Jun-22-2026 8:10 a.m. ET

With GLP-1 medication demand climbing throughout the U.S., CVS Health® unveiled today a wide-ranging GLP-1 strategy that reaches across its 9,000-plus CVS Pharmacy® sites and MinuteClinic®, the latter offered virtually in almost every state. Among the additions: broader pharmacy support meant to assist patients in getting these treatments and remaining on them, plus a $49 MinuteClinic virtual visit where eligible adults meet licensed clinicians able to assess them and, when clinically appropriate, write a GLP-1 prescription.

Three elements make up this new approach: 1.lower-cost access, 2.personalized pharmacist support, and 3. over-the-counter products to help manage common side effects, which are three of the biggest barriers patients face when starting GLP‑1 therapy.

A wide selection of GLP‑1 prescription drugs is carried by CVS Pharmacy, covering injectable and oral products from several manufacturers, alongside new digital tools on CVS.com. Combined with advice from familiar neighborhood pharmacists, these resources aim to carry patients from the first dose through continued treatment. "Access is only part of the equation with GLP‑1 medications. Patients also need support to stay on therapy and see results," said Sid Tenneti, Senior Vice President and Interim President, Pharmacy and Consumer Wellness. "From helping patients manage side effects to identifying ways to lower costs, our pharmacists are there every step of the way."

Lower cost access to GLP-1 medications To help address cost concerns, CVS Pharmacy will begin participating in the Centers for Medicare & Medicaid Services (CMS) Medicare GLP‑1 Bridge program starting July 1, 2026. Through the program, which runs through December 31, 2027, eligible Medicare beneficiaries can access certain GLP‑1 medications for $50 per month, offering more predictable and affordable pricing for patients who qualify.

For those not eligible, CVS Pharmacy accepts a wide range of third-party prescription discount cards, manufacturer coupons, and manufacturer vouchers to help reduce out-of-pocket costs. At CVS Pharmacy, the out-of-pocket cost for a GLP-1 medication can be as low as $25 a month through commercial insurance with a manufacturer coupon for eligible patients, or $149 for those without insurance who utilize a manufacturer voucher for qualifying medications and doses. CVS Pharmacy is a retail pharmacy partner for NovoCare®, a program that offers discounted Wegovy® and Ozempic®, and was the first to build a streamlined NovoCare enrollment experience.

Pharmacists at the center of care As more patients turn to GLP‑1 medications, CVS Pharmacy is emphasizing the role of its pharmacists in helping patients navigate treatment.

According to the CVS Health (CVS) 2025 Rx Report, nearly half of consumers prioritize personalized care at the pharmacy, and many prefer in-person pharmacy support over digital-only options - highlighting the ongoing importance of face-to-face interactions with pharmacists. From answering questions about dosing to helping patients manage side effects and stay on track, CVS pharmacists play a critical role in supporting the overall treatment experience and are available when it is convenient for the patient.

Clinical weight loss support available at MinuteClinic MinuteClinic is broadening its virtual care platform with the launch of a new digital health offering that connects eligible adults with licensed clinicians to evaluate their weight loss and metabolic health needs and, where clinically appropriate, prescribe FDA-approved GLP-1 medications for weight loss.

At $49 per visit with no recurring membership or monthly fee, the program is built to make a first step toward weight management straightforward and affordable. Patients begin with a virtual video visit with a licensed physician associate or nurse practitioner, who reviews their health history and weight-management goals before determining whether a GLP-1 therapy is the right fit. Those who start treatment can schedule follow-up visits as needed for dose adjustments, side-effect support, and ongoing monitoring.

The program is available in 47 states and Washington, D.C., and is designed for self-pay adults ages 18 to 64 who are overweight or living with obesity and intend to pay out of pocket for clinical weight loss services. Patients seeking weight loss or metabolic health clinical support can visit MinuteClinic.com.

Over-the-counter products to help manage side effects Side effects remain one of the leading reasons patients discontinue GLP‑1 therapy. To help address this, CVS Pharmacy has expanded its product assortment and is highlighting CVS brand and national brand over-the-counter products to help make managing side effects easier. Pharmacists can discuss concerns and help manage side effects in collaboration with prescribers.

In select locations, dedicated product displays highlight items that can help manage common issues such as nausea and gastrointestinal discomfort, as well as products that support hydration, protein intake, and overall nutrition. These in-store curated displays, sponsored by Haleon, are designed to bring together pharmacist guidance and practical, easy-to-find products to make it simpler for patients to manage their treatment.

Customers can also select from a wide array of CVS brand products found throughout the store to help manage common GLP-1 side effects that offer the quality and value customers have come to expect from CVS Pharmacy store brands
 
To qualify for coverage, the pharmacy needs to receive a prescription from the provider first. From there, a Prior Authorization request for the Bridge program is set off, and the chart has to contain documentation showing a BMI of 30

or above. The provider has to fill that out to confirm the person meets the criteria. That request is then sent by the provider straight to Humana, the company CMS picked to handle Bridge approvals.

After a request is fully approved, the patient pays the $50 flat copayment at the pharmacy counter when picking up the medication.

The GLP-1s that may be prescribed for obesity are Novo's Wegovy injection along with the tablet version of that drug, plus Lilly's competing pill Foundayo and its obesity shot Zepbound in the KwikPen formulation.

A separate Prior Authoirzation {PA} made specifically for the Medicare GLP! Bridge Program is required to receive the $50/month price. Since the Medicare GLP BRIDGE Program runs entirely outside the normal Kaiser Medicare Part D framework, having only the Zepbound KwikPen prescription will not make the $50 promotional price appear at Kaiser pharmacy cash registers.

That particular Zepbound form was the only one Lilly put in the program because a single pen holds a full month of doses, which makes it simpler for providers to administer. What matters is that your doctor's prescription corresponds to one of these approved Eli Lilly NDC for the Zepbound KwikPen:

0002-3566-11

0002-3555-11

0002-3544-11

0002-3533-11

0002-3522-11

0002-3511-11
 
Two days ago I got my doctor to write the prescription through the Bridge. We talked about how to handle the sleep apena issue, and with a wink, wink he told me: [[Q1]] (Which is ridiculous — I've checked recently with a bluetooth pulse oximeter and I still dip.)

So the question now is whether Humanna will cross-check my records and reject me on the pre-auth. I should find out within a day or two (and I'm also wondering how long this whole process is going to take).
 
My good friend, who is obese, got a Wegovy prescription yesterday, even though he had bad reactions to it last year. He has already completed Kaiser's weight loss class. His Kaiser physician appears unwilling to prescribe Zepbound Kwikpen, since that would set off a prior authorization requirement so it could be filled at a pharmacy outside Kaiser. I recommended that he look into a telehealth provider consultation as a way to obtain a prior authorization prescription. https://www.cms.gov/files/document/glp-1-bridge.pdf
 
I just went to the WW site, which walks you through the BRIDGE program authorization process — $99/month for Zepbound Kwikpen multi-dose pens, along with a telehealth doctor prescription.
 
Good-Heart6425 said:

I just went to the WW site, which walks you through the BRIDGE program authorization process — $99/month for Zepbound Kwikpen multi-dose pens, along with a telehealth doctor prescription.
Click to expand...
If Bridge covers it, how come the cost is $50 a month instead of something else? Does WW charge an extra $50 each month as its own fee?
 
Good-Heart6425 said:

I just went to the WW site, which walks you through the BRIDGE program authorization process — $99/month for Zepbound Kwikpen multi-dose pens, along with a telehealth doctor prescription.
Click to expand...
What's the point of bringing WW into this? (Especially when it adds $49/month?)
 
Sharing my experience in case anyone else finds it helpful — this is how my 1st week of attempting to get "on the bridge" went:

- My PCP sent the prescription over to CVS, with a note reading "for CMS bridge". CVS went ahead and forwarded it to my insurance regardless, and it came back denied.

- The PCP sent it to CVS a 2nd time, same notation. I got on the phone with them right away and asked that it be routed to the Bridge. Their response was to have me come in so they could look at my Medicare card and my UHC Advantage. I went. We reviewed the prescription together. What I learned is that a PCP simply writing "for the bridge" program does NOT satisfy the requirement — the plan's BIN and PCN numbers have to be supplied as well.

After that, CVS fixed it and transmitted the script correctly to Humana, and a Bridge PA request ought to reach my PCP soon (possibly through their CoverMyMeds electronic prior-auth (ePA) system).
 
IT WENT THROUGH! Monday morning, bright and early, an ePA landed on my doctor's CoverMyMeds ePA platform. He completed it, and roughly 4 hours afterward the approval came through. Wow. SO I AM ON THE BRIDGE. (I also had him write me for 15mg, so I can stockpile.) Good-bye RUO chemicals bought from strangers on the Internet (at least until 2028 anyway).

So, at this time, they DO NOT appear to be cross-checking your records for things like Sleep Apnea, they just focus on the info in the prescription itself. So if you can get your Doc to look past that sort of thing, should need be, you're good to go. So, get on it, old people!

(Pharmacist said on Saturday she was seeing 80-90% acceptance rates into the bridge, which is encouraging...)
 
PatchyFog said:

IT WENT THROUGH! Monday morning, bright and early, an ePA landed on my doctor's CoverMyMeds ePA platform. He completed it, and roughly 4 hours afterward the approval came through. Wow. SO I AM ON THE BRIDGE. (I also had him write me for 15mg, so I can stockpile.) Good-bye RUO chemicals bought from strangers on the Internet (at least until 2028 anyway).

So, at this time, they DO NOT appear to be cross-checking your records for things like Sleep Apnea, they just focus on the info in the prescription itself. So if you can get your Doc to look past that sort of thing, should need be, you're good to go. So, get on it, old people!

(Pharmacist said on Saturday she was seeing 80-90% acceptance rates into the bridge, which is encouraging...)
Click to expand...
Alternatively, PT-141 could be stockpiled too, haha.
 
Back
Top